ZEB1 and breast cancer: Although precise alterations of the ZEB/miR-200 balance are able to switch breast cancer cells back and forth between epithelial and mesenchymal states, the induction and maintenance of a stable mesenchymal phenotype requires the establishment of autocrine TGF-β signaling that supports sustained ZEB expression [38].